Mankind Pharma Limited (NSE:MANKIND)
2,235.00
+71.70 (3.31%)
Mar 10, 2026, 1:00 PM IST
Mankind Pharma Revenue
Mankind Pharma had revenue of 35.67B INR in the quarter ending December 31, 2025, with 10.44% growth. This brings the company's revenue in the last twelve months to 139.14B, up 19.53% year-over-year. In the fiscal year ending March 31, 2025, Mankind Pharma had annual revenue of 122.07B with 18.98% growth.
Revenue (ttm)
139.14B
Revenue Growth
+19.53%
P/S Ratio
6.42
Revenue / Employee
7.09M
Employees
19,620
Market Cap
893.02B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zydus Lifesciences | 260.89B |
| Cipla | 279.67B |
| Aurobindo Pharma | 331.82B |
| Alkem Laboratories | 142.53B |
| Glenmark Pharmaceuticals | 165.10B |
| Laurus Labs | 67.22B |
| Divi's Laboratories | 103.14B |
| Ipca Laboratories | 95.06B |